Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000227214 | SCV000287294 | benign | Atrioventricular septal defect 4 | 2024-01-30 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000617783 | SCV000736184 | benign | Cardiovascular phenotype | 2016-10-27 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV001589178 | SCV001815275 | likely benign | not provided | 2020-12-10 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV001796730 | SCV003934814 | benign | not specified | 2023-05-28 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001589178 | SCV004564038 | benign | not provided | 2023-09-22 | criteria provided, single submitter | clinical testing | |
Laboratory of Diagnostic Genome Analysis, |
RCV001589178 | SCV002036282 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001796730 | SCV002037996 | benign | not specified | no assertion criteria provided | clinical testing |